Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.35 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1414278 | 0.96 | FDPS (0.41) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL6413193 | 0.80 | — | — | |
| SCHEMBL3900432 | 0.67 | — | — | |
| SCHEMBL1224912 | 0.67 | FDPS (0.33) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3440713 | 0.67 | — | — | |
| SCHEMBL24496310 | 0.67 | CHRNA7 (0.42) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2499397 | 0.67 | FDPS (0.33) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL57304 | 0.67 | — | — | |
| SCHEMBL24233286 | 0.67 | SMN1; SMN2 (0.40) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19444873 | 0.67 | DPP7 (0.36) | FDPSCYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9975844-B2 | Method for producing nitro compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9822061-B2 | Method for producing nitro compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170144961-A1 | METHOD FOR PRODUCING NITRO COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-25 | — | — | US | disclosed |
| US-20170129846-A1 | METHOD FOR PRODUCING NITRO COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-0608725-B1 | Process for preparing aminomethylene compounds | BAYER AG (DE) | 2000-05-17 | — | — | EP | disclosed |
| US-5401869-A | Process for the preparation of aminomethylene compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-28 | — | — | US | disclosed |
| EP-0608725-A2 | Process for preparing aminomethylene compounds | BAYER AG (DE) | 1994-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170144961-A1 | METHOD FOR PRODUCING NITRO COMPOUND | NOS2, CYP11B2, NOS1 | FDPS 400/4885CYP1A2 50/4885CYP3A4 164/4885 |
| US-20170129846-A1 | METHOD FOR PRODUCING NITRO COMPOUND | NOX1, NOS1, NOX3 | FDPS 2781/4885CYP1A2 27/4885CYP3A4 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.